Michael Kearney is Clairity’s Vice President of Market Access. He brings more than 15 years of experience in biotech, healthcare operations, and launch strategy.

Prior to joining Clairity, Michael was Senior Director of Market Access at GRAIL, where he developed and executed coverage strategies that drove broad adoption of the company’s flagship screening product. Prior to GRAIL, he served as Director of Market Access at Avalere Health, advising life sciences companies on payer strategy and commercialization. His background spans finance, revenue cycle, care delivery, and policy, giving him a unique perspective on how market access decisions shape both patient care and business growth.

Michael holds a B.S. in Corporate Finance from Boston College.